Toronto, Ontario — (Newsfile Corp. – February 21, 2024) – Safe Supply Streaming Co. Ltd. (CSE: SPLY)) (FSE: QM4) (OTCQB: SSPLF) (“secure supply” or “company”) commends the British Columbia Association of Naturopathic Doctors (BCND) for their proactive stance towards increasing the prescribing authority of British Columbia naturopathic doctors. This initiative represents an important step toward a safer supply and integration of pharmacotherapy for substance use disorders, and allows naturopathic physicians to play a critical role in responding to this public health emergency. It highlights gender.
Safe Supply is at the forefront of this movement and is in active discussions with several clinics in British Columbia and Ontario. We are strategically positioning ourselves as a preferred supplier as we look to expand our prescribing authority within the naturopathic community. Additionally, Safe Supply is exploring clinic roll-ups and acquisition opportunities with the aim of strengthening its ecosystem and reinforcing its efforts to effectively address the toxic drug crisis.
The BC Association of Naturopathic Physicians says there is significant interest in the topic among its members, and that more than 250 naturopathic doctors are educating the province to prescribe drugs commonly used for opioid use disorder, such as methadone. Reports being enrolled in a training program. This effort reflects the community’s dedication to being part of a comprehensive solution to the crisis. To date, 50 of his members from 30 communities have begun training, underscoring the urgency and commitment of naturopathic professionals to contribute meaningfully to this public health challenge.
In response to this initiative, BCND President Vanessa Lindsay contacted BC’s Minister of Mental Health and Addictions to advocate for necessary changes to allow naturopathic doctors to prescribe medication for substance use disorders. This proposal has been sent to Health Minister Adrian Dix and represents a positive step towards legislative and regulatory support for this important issue.
A recent study published in the British Medical Journal, including a population-level evaluation, found that the effectiveness of prescribing alternatives to illicit drugs in reducing overdose deaths and related harms. has been proven. Despite the obvious benefits, access to these prescriptions remains limited and the majority of people who use illicit drugs in B.C. do not have access to prescribed alternatives.
Safe Supply works closely with healthcare providers, clinics, and regulators to expand access to safer supply options and become an integral part of the solution. As discussions progress, Safe Supply is committed to supporting initiatives that lead to concrete changes in policy and practice, ultimately contributing to the health and well-being of communities in Columbia and Ontario. .
Acquisition of shares in Safety Strip
Safe Supply also provides details on its recently announced acquisition of a 7% interest in Safety Strips Tech Corp. (“safety strip), a pioneering harm reduction company (see press release of February 8, 2024).
Safe Supply Streaming will acquire a 7% interest in Safe Supply Strips Tech Corp. for $50,000 in cash and 3 million shares of Safe Supply common stock for a total consideration of $300,000 (CAD $0.10 per share). Acquired minority interest in Safety Strips Tech Corp.
Safe Supply’s CEO, Bill Panagiotakopoulos, independently owns approximately 4,000,000 shares of Safety Strips Tech Corp., representing 7.5%.
Safe Supply’s participation in Safety Strip’s founder round highlights the tangible value Safe Supply provides to companies combating the opioid crisis. This introduces Safe Supply’s unique model of incubating, accelerating and partnering with companies to acquire significant stakes in companies with significant potential. Reflecting on the opportunity to invest in a $5 million safety strip. The serial entrepreneur and former public co-CEO has a U.S. distribution agreement and active discussions with retailers.
As the fentanyl crisis continues to grow, SafetyStrip is positioned to lead the development of harm reduction technology. This acquisition represents a significant step forward in addressing the escalating overdose crisis and positions Safe Supply Streaming at the forefront of the emerging medical testing market.
About safe supply
Safe Supply Streaming is a publicly traded company committed to improving public health outcomes through strategic investments in harm reduction and medical technology. Safe Supply Streaming aims to address critical health crises and deliver meaningful, life-saving interventions by focusing on innovative solutions and partnerships.
For more information, please visit www.safesupply.com. Also, follow Safe Supply on LinkedIn, Twitter, and Instagram.
For more information:
Bill Panagiotakopoulos
CEO and Director
(305) 335-8214
bill@safesupply.com
Media contact:
mckenna miller
KCSA Strategic Communications
safesupply@kcsa.com
Forward-looking information and statements
Certain statements in this news release relating to secure supply and origin are forward-looking statements and do not reflect express or implied statements and assumptions regarding origin and secure supply’s intent to complete the transaction. are forward-looking in nature, including but not limited to: Forward-looking statements are not historical facts but are based on current expectations and projections about future events, which could cause actual results to differ materially from any future results expressed or implied by the forward-looking statements. may be subject to certain risks and uncertainties. . These forward-looking statements generally include statements such as “may,” “should,” “could,” “intend,” “estimate,” “plan,” “anticipate,” and “expect.” can be identified by the use of forward-looking language such as , “believe,” “will,” “continue,” or their negatives, or similar variations. There are a number of risks and uncertainties that could cause actual results, Origin and Safe Supply’s plans and objectives to differ materially from those expressed in the forward-looking information. This includes, but is not limited to, adverse market conditions and risks inherent in Origin’s and Safe Supply’s respective businesses. . Actual results and future events may differ materially from those anticipated in such information. These and all subsequent written and oral forward-looking information are based on management’s estimates and opinions as of the date made and are expressly warranted in their entirety by this press release. Origin and Safe Supply do not intend to update these forward-looking statements except as required by applicable law. Without limiting the generality of the foregoing, there can be no assurance that the Transaction will be completed as proposed or at all. Investors acknowledge that, except as disclosed in the management information circular and/or listing statement prepared in connection with the Transaction, information released or received in connection with the Transaction may not be accurate or complete; Note that it should not be trusted. Trading securities of origin should be considered highly speculative.
CSE has neither approved nor disapproved the contents of this news release and is not responsible for its adequacy or accuracy.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/198734.
